156 related articles for article (PubMed ID: 35989390)
1. Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound.
Keller J; Stern S; Chang SC; Marcus R; Weiss J; Nassoiy S; Christopher W; Fischer T; Essner R
Ann Surg Oncol; 2022 Dec; 29(13):8469-8477. PubMed ID: 35989390
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
Cochran AJ; Wen DR; Huang RR; Abrishami P; Smart C; Binder S; Scolyer RA; Thompson JF; Stern S; Van Kreuningen L; Elashoff DE; Sim MS; Wang HJ; Faries MB;
Eur J Surg Oncol; 2022 Jun; 48(6):1280-1287. PubMed ID: 35246348
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases.
Parvez E; Khosrow-Khavar F; Dumitra T; Nessim C; Bernard-Bédard É; Rivard J; Pravong V; Wang S; Gervais MK; Meterissian S; Dumitra S
Ann Surg Oncol; 2023 Feb; 30(2):1195-1205. PubMed ID: 36282456
[TBL] [Abstract][Full Text] [Related]
5. Real-World Adherence to Nodal Surveillance for Sentinel Lymph Node-Positive Melanoma.
Montgomery KB; Correya TA; Broman KK
Ann Surg Oncol; 2022 Sep; 29(9):5961-5968. PubMed ID: 35608800
[TBL] [Abstract][Full Text] [Related]
6. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
7. New Zealand patients have a higher melanoma burden in sentinel nodes and completion lymphadenectomy than patients in MSLT-II.
Williams TS; Arahill-Whitham J; Bailey TA; Hayward G; Li A; Tallon B; Wen D; Adams BM
J Plast Reconstr Aesthet Surg; 2023 Aug; 83():98-105. PubMed ID: 37271003
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
[TBL] [Abstract][Full Text] [Related]
9.
Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
[TBL] [Abstract][Full Text] [Related]
10. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
11. Management of the positive sentinel lymph node in the post-MSLT-II era.
Bredbeck BC; Mubarak E; Zubieta DG; Tesorero R; Holmes AR; Dossett LA; VanKoevering KK; Durham AB; Hughes TM
J Surg Oncol; 2020 Dec; 122(8):1778-1784. PubMed ID: 32893366
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples. Results from 240 sentinel node biopsies.
Caracò C; Chiofalo MG; Niro J; Ascierto PA; Botti G; Lastoria S; Mozzillo N
Tumori; 2002; 88(3):S12-3. PubMed ID: 12365370
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm).
Holmberg CJ; Mikiver R; Isaksson K; Ingvar C; Moncrieff M; Nielsen K; Ny L; Lyth J; Olofsson Bagge R
Ann Surg Oncol; 2023 Dec; 30(13):8026-8033. PubMed ID: 37574516
[TBL] [Abstract][Full Text] [Related]
15. Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients.
Ribero S; Osella Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P;
Dermatology; 2017; 233(2-3):205-211. PubMed ID: 28738392
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
[TBL] [Abstract][Full Text] [Related]
17. Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience.
Williams TS; Tallon B; Adams BM
J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):730-736. PubMed ID: 34789434
[TBL] [Abstract][Full Text] [Related]
18. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients.
Balkin DM; Tranah GJ; Wang F; O'Donoghue C; Morell EA; Porubsky C; Nosrati M; Vaquero EM; Kim H; Carr MJ; Montilla-Soler JL; Wu MC; Torre DM; Kashani-Sabet M; Zager JS; Leong SP
Cancer Control; 2023; 30():10732748231153775. PubMed ID: 36705261
[TBL] [Abstract][Full Text] [Related]
19. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
[TBL] [Abstract][Full Text] [Related]
20. The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
Tropea S; Del Fiore P; Maurichi A; Patuzzo R; Santinami M; Ribero S; Quaglino P; Caliendo V; Borgognoni L; Sestini S; Giudice G; Nacchiero E; Caracò C; Cordova A; Solari N; Piazzalunga D; Tauceri F; Carcoforo P; Lombardo M; Cavallari S; Mocellin S;
BMC Cancer; 2022 Jun; 22(1):610. PubMed ID: 35659273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
